Lab
Laboratorio Clinico Ocean Blue, INC.
Laboratorio Clinico Ocean Blue, INC. was paid $1.13M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is G2023, Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source — 11% of everything it billed.
33Billing provider infoLABORATORIO CLINICO OCEAN BLUE, INC.
LOIZA, PR 00772
LOIZA, PR 00772
33aNPI1619151487assigned 12/28/2007
33bProvider typeClinical Medical Laboratory
28Total paid$1.13M
24GClaims90,668
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#106 of 777
Median peer was paid$278K
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,540 | $95K | |
| 2019 | 9,764 | $87K | |
| 2020 | 9,663 | $131K | |
| 2021 | 17,787 | $278K | |
| 2022 | 14,316 | $207K | |
| 2023 | 16,073 | $172K | |
| 2024incomplete | 13,525 | $156K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 11% | 5,586 | 4,917 | $129K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10% | 2,316 | 2,194 | $115K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.7% | 2,789 | 2,419 | $98K |
| 80061 | Lipid panel | 8.5% | 7,762 | 7,136 | $96K |
| 84443 | Thyroid stimulating hormone (TSH) | 8.3% | 6,087 | 5,595 | $94K |
| 80053 | Comprehensive metabolic panel | 7.7% | 8,976 | 8,172 | $87K |
| 36415 | Collection of venous blood by venipuncture | 5.1% | 8,422 | 7,315 | $57K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.8% | 2,106 | 1,958 | $54K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.3% | 7,039 | 6,336 | $48K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.2% | 5,350 | 4,904 | $48K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.0% | 1,064 | 983 | $34K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.0% | 1,057 | 979 | $34K |
33 more codes
| 81000 | 2.5% | 9,177 | $28K | |
| 82274 | 2.4% | 1,898 | $27K | |
| 86703 | 2.4% | 2,229 | $27K | |
| 85027 | 2.2% | 4,322 | $25K | |
| 86328 | 1.7% | 1,052 | $20K | |
| 82043 | 1.1% | 2,347 | $12K | |
| 84480 | <1% | 799 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,281 | $10K |
| 87088 | <1% | 1,225 | $9K | |
| 80074 | <1% | 194 | $9K | |
| 84439 | <1% | 1,047 | $9K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 529 | $6K |
| 86592 | <1% | 1,493 | $6K | |
| 84153 | <1% | 334 | $6K | |
| 84436 | <1% | 802 | $5K | |
| 86738 | <1% | 385 | $5K | |
| 87177 | <1% | 622 | $5K | |
| 82570 | <1% | 878 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 56 | $3K |
| 82607 | <1% | 181 | $2K | |
| 82951 | <1% | 102 | $986.45 | |
| 85670 | <1% | 182 | $937.11 | |
| 86803 | <1% | 51 | $733.50 | |
| 85610 | <1% | 178 | $615.03 | |
| 86704 | <1% | 36 | $400.80 | |
| 86708 | <1% | 35 | $400.03 | |
| 83655 | <1% | 36 | $370.89 | |
| 86706 | <1% | 37 | $367.36 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 17 | $337.14 |
| 85651 | <1% | 92 | $303.85 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 472 | $251.91 |
| 87340 | <1% | 13 | $117.01 | |
| 84156 | <1% | 12 | $30.70 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPAGAN OQUENDO, ANGEL (PRESIDENT)